Clinical Trial Update: A Study of Efficacy and Safety of Glofitamab in Combination With Salvage Therapy in a Real-world Setting in Chinese Adult Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma.

View source ↗

Summary

This clinical trial update describes a study evaluating the efficacy and safety of glofitamab in combination with salvage therapy for relapsed or refractory B-c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Non-hodgkin Lymphoma

Drugs mentioned

• Glofitamab (glofitamab)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: B-cell Non-Hodgkin Lymphoma | Status: RECRUITING